WHO to resume hydroxychloroquine trials

The World Health Organization (WHO) approves the continuation of the solidarity trials on hydroxychloroquine — a potential drug for the coronavirus treatment — after briefly suspending it over safety concerns, Director General of the WHO Tedros Adhanom Ghebreyesus said Wednesday.

«On the basis of the available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol», Tedros told a pres conference.

The Executive Group received this recommendation and endorsed continuation of all arms of the Solidarity Trial, including hydroxychloroquine, he added.